BioSpace News Archive

Business

Market Update: Commonwealth Biotechnologies, Inc. Reports New Drug Discovery Contract Signings and Growth Initiatives

April 8, 2008
·
1 min read
Drug Development

Seattle Genetics, Inc. Announces Initiation of Phase Ib Clinical Trial of SGN-40 in Combination with Rituxan and Gemzar for Non-Hodgkin Lymphoma

April 8, 2008
·
1 min read
Haemacure Corporation Announces Details of its Annual General and Special Meeting of Shareholders

April 8, 2008
·
2 min read
Drug Development

New Clinical Data on AVEO Pharmaceuticals, Inc.’ Investigational Triple VEGFR Small Molecule Inhibitor AV-951 to be Presented at American Association for Cancer Research Annual Meeting

April 8, 2008
·
1 min read
Business

Oncolin Therapeutics, Inc. Announces It Has Entered into Negotiations with a Leading Institution to Commercially Develop a Cancer Technology

April 8, 2008
·
1 min read
Drug Development

DiaKine Therapeutics, Inc. Release: Combination Drug Therapy May Hold the Key to Reversing Type 1 Diabetes

April 8, 2008
·
1 min read
Business

QuantRx Biomedical Corporation Announces Exclusive Manufacturing and Distribution Agreement for New Presumptive Field Narcotics Testing Products with Fieldtests LLC

April 8, 2008
·
1 min read
Pharm Country

Pfizer Inc. Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals

April 8, 2008
·
1 min read
Business

NanoLogix, Inc. Provides Financial Update

April 8, 2008
·
2 min read
Drug Development

MAP Pharmaceuticals, Inc. Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics; Asthma Drug Meets Midstage Goal

April 8, 2008
·
6 min read